FDA Brief

Warning letters Food

FDA warning letter to

TeaTaze, LLC

High riskIssued Jul 23, 2021Posted Aug 24, 2021Office of Human and Animal Food- West Division II

TeaTaze marketed eight teas with claims they treat diseases, including COVID-19, making them unapproved new drugs, FDA says.

What happened

FDA reviewed the company's website, www.teataze.com, in March and April 2021, plus its Facebook page, which sends shoppers to that website to buy. FDA found blog posts and social media claims that the teas fight cancer, lower blood pressure, treat anxiety, prevent diabetes and, for Clean Green Energy Detox, help fight viruses such as COVID-19. FDA found no inspection; the case came from the website and social media review.

What FDA found

  1. The website claims the teas cure, treat or prevent diseases, which makes them drugs under the law.

    Section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 321(g)(1)(B)]
  2. These teas are not generally recognized as safe and effective for those uses, so they are 'new drugs' — a drug that needs FDA approval before it can be sold.

    Section 201(p) [21 U.S.C. 321(p)]; sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]
  3. The Clean Green Energy Detox tea was promoted as helping fight COVID-19 and other viruses.

    Sections 201(g)(1)(B) and 505(a) [21 U.S.C. 321(g)(1)(B), 355(a)]
  4. The products give no adequate directions for use for the disease uses claimed, so a layperson could not use them safely, and they are misbranded.

    Section 502(f)(1) [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  5. Shipping these misbranded drugs across state lines violates the law.

    Section 301(a) [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to stop selling any unapproved products claimed to prevent or treat COVID-19 right away. It must also write to FDA within 15 working days describing the steps taken to fix the violations and prevent them from recurring, or explain why more time is needed.

Who should pay attention

  • tea, herbal and supplement brands that make health claims on websites and blogs
  • e-commerce sellers and social media marketers of beverages
  • labeling and advertising reviewers at food and beverage companies

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk